AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding AIM ImmunoTech Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 38 | 39 | +1 |
| Shares | 7.42M | 7.21M | −215.9K (−2.9%) |
| Value | $16.8M | $15.5M | −$1.36M (−8.1%) |
New holders (10)
Institutions that held AIM ImmunoTech Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 160,413 | $345.0K | 0.00% |
| Dimensional Fund Advisors LP | 139,160 | $299.0K | 0.00% |
| Winton Group Ltd | 54,894 | $118.0K | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 47,950 | $103.0K | 0.00% |
| XTX Topco Ltd | 29,269 | $63.0K | 0.02% |
| SNS Financial Group, LLC | 10,000 | $22.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 9,733 | $21.0K | 0.00% |
| Proequities, Inc. | 500 | $1.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
| Royal Bank of Canada | 14 | $0 | 0.00% |
Sold out (9)
Institutions that held AIM ImmunoTech Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Citadel Advisors LLC | 103,283 | $234.0K |
| Gsa Capital Partners LLP | 74,790 | $170.0K |
| Virtu Financial LLC | 29,484 | $67.0K |
| Engineers Gate Manager LP | 17,900 | $41.0K |
| Susquehanna Fundamental Investments, LLC | 17,000 | $39.0K |
| Steward Partners Investment Advisory, LLC | 5,000 | $11.3K |
| Bank of Montreal | 5,000 | $11.0K |
| Global Wealth Management Investment Advisory, Inc. | 600 | $1.00K |
| Citigroup Inc | 120 | $0 |